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explained by additive genetic effects, independent of sex 
and age. The HFE genotypes explained a considerable pro-
portion of serum iron parameters and may be an important 
factor in the complex iron network. 
 Copyright © 2006 S. Karger AG, Basel 
 Introduction 
 Iron plays an important role in biochemical reactions 
 [1, 2] . Low iron levels are associated with iron deficiency 
anaemia  [2] . Increased iron stores in the body have been 
linked to several diseases including vascular disease(s)  [3, 
4] , Parkinson’s disease  [5] , diabetes mellitus  [6] , arthritis 
 [7] and liver diseases  [8] .
 Body iron status is not only influenced by genes but 
also by environmental factors like diet, iron intake, blood 
loss, pregnancy, alcohol intake and infections  [9, 10] . In 
order to maintain iron levels within normal ranges and 
thus prevent the pathologic consequences of iron excess 
or iron deficiency, iron homeostasis has evolved as a com-
plex trait and a tightly coordinated process of interplay 
between genes and environmental factors in order to 
maintain iron levels within the normal range. Several 
genes are known that are involved in iron regulation in 
humans including the hereditary hemochromatosis gene 
(HFE), the ferroportin1 gene (FPN1), the divalent metal 
transporter gene (DMT1), the hepcidin antimicrobial 
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 Abstract 
 Background: Iron has been implicated in the pathogenesis 
of various disorders. Mutations in the HFE gene are associ-
ated with an increase in serum iron parameters. The aim of 
this study was to estimate the heritability in serum iron pa-
rameters explained by HFE.  Methods: Ninety families (980 
subjects) were included in the present analysis. Heritability 
estimation was conducted using the variance component 
method. The likelihood ratio test was used to compare mod-
els. Phenotypic and genetic correlations between serum 
iron parameters were calculated.  Results: The heritability (h 2  
 8 SE) estimates were 0.23  8 0.07 (p  ! 0.0001) for iron, 0.29 
 8 0.09 (p  ! 0.0001) for ferritin and 0.28  8 0.07 (p  ! 0.0001) 
for transferrin saturation while adjusting for age, age 2  and 
sex. The HFE genotypes explained between 2 to 6% of the 
sex and age-adjusted variance in serum iron, ferritin and 
transferrin saturation. There was a high genetic correlation 
between serum iron parameters, suggesting pleiotropy be-
tween these traits.  Conclusion: A substantial proportion of 
the variance of iron, ferritin and transferrin saturation can be 
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peptide (HAMP), the hemochromatosis type 2 gene 
(HFE2), and the transferin receptors gene (TFR)  [11–16] . 
Mutations in these genes have been implicated in heredi-
tary hemochromatosis, a disorder of iron metabolism, in 
which there is increased absorption and storage of iron in 
body tissues. The common and most important gene is 
HFE. The HFE gene has two main mutations, the C282Y 
and the H63D mutations. These two mutations are found 
in 85% of patients with hemochromatosis and are also as-
sociated with increased body iron concentrations in the 
general population  [13] . HFE mutations are not fully pen-
etrant and their contribution to the overall genetically 
determined variation in iron pool has not been clearly 
established.
 Crawford et al.  [17] studied the concordance of iron 
storage in siblings with genetic hemochromatosis. They 
found that siblings of similar sex accumulate similar 
amounts of liver iron. Their study demonstrated that iron 
storage in hemochromatosis is predominantly under ge-
netic control. In a similar study, Whiting et al.  [18] re-
ported a concordance of iron indices in C282Y homo-
zygote(s) and heterozygote(s) sibling pairs. There is only 
one twin study known on the heritability of iron param-
eters. Whitfield et al.  [19] reported that 23 and 31% of the 
variance in iron, 66 and 49% of the variance in transfer-
rin, 33 and 47% of the variance in transferrin saturation 
and 47 and 47% of the variance in ferritin, in men and 
women respectively, could be explained by additive ge-
netic factors. However, this study did not address the 
question to what extend serum iron parameters are ex-
plained by known genes such as HFE. Lazarescu et al. 
 [20] reported a residual heritability of 35% for serum fer-
ritin in subjects with the C282Y genotype. Their study 
did not address other valuable iron parameters like se-
rum iron and serum transferrin saturation, which are im-
portant for clinical diagnosis.
 We estimated the proportion of serum iron, ferritin 
and transferrin saturation due to genetic factors and the 
proportion that could be explained by the HFE gene us-
ing a large family-based sample from a genetically iso-
lated population in the Netherlands. Further, we estimat-
ed the genetic and phenotypic correlations between these 
traits.
 Material and Methods 
 Study Population
 This study was carried out within a family-based study of 
3,000 inhabitants of a genetically isolated community in the 
Southwest of the Netherlands, the Erasmus Rucphen Family 
(ERF) study. The ERF study has been described in detail else-
where  [21] . Briefly, about 150 people who migrated to the area in 
the middle of the 18th century founded the study population. 
Since then there has been little emigration and immigration in the 
area and considerable population expansion. At present, there are 
about 20,000 inhabitants all living in 8 adjacent villages. The aim 
of the ERF study is to unravel the genetic determinants of complex 
diseases and the medical ethics committee of the Erasmus Medi-
cal Centre Rotterdam has approved this study. Informed consent 
and authorization to inspect and use medical records were ob-
tained from all participants.
 Family Structure 
 The (first) 980 participants considered in the present study 
came from 90 families and included 369 parent-offspring pairs, 
561 sibling pairs, 41 half-sibling pairs, 872 avuncular pairs, 32 
grandparent-grandchild pairs, 52 half avuncular pairs, 2,258 first 
cousins pairs, 50 half first cousin pairs.
 Phenotypic Measurements 
 Participants were invited for a battery of clinical examinations 
at the research centre. Each participant provided blood samples 
and further information was obtained during an interview at the 
research centre and after participants returned a take-home ques-
tionnaire. Fasting blood samples were drawn by venepuncture 
between 7:  00 and 10:  00 a.m. Serum samples were obtained from 
whole blood and plasma samples were obtained from blood col-
lected in EDTA.
 The serum ferritin was measured by a solid-phase, two-site 
chemiluminescent immunometric assay (Immulite 2000, Diag-
nostic Products Corporation, Cirrus). Total serum iron was mea-
sured by colorimetric assay with the use of ascorbate/FerroZine 
reagents from Roche on an Aeroset from Abbott. The unsaturated 
iron binding capacity (UIBC) was measured by adding a known 
quantity of Fe(III) to the serum sample, reducing it with ascorbate 
to Fe(II) and measuring it with FerroZine as described above 
(Roche reagents on an Aeroset). The total iron binding capacity 
(TIBC) was calculated as: Fe + UIBC = TIBC. Serum transferrin 
saturation (%) was calculated as follows: (serum iron/TIBC)  ! 
100%. Genotyping of the HFE C282Y and H63D variants were 
done as described elsewhere  [22] .
 Statistical Analyses 
 The heritability of serum iron parameters was estimated using 
the variance component method as implemented in the program 
SOLAR  [23] . The heritability is calculated by partitioning the 
phenotypic variance (Vp) of the serum iron parameter into com-
ponents that include the additive effect of genes or polygenic vari-
ance (Vg), the variance due to measured environmental risk fac-
tors (Ve) such as age, sex and other covariates, and the residual or 
non-shared environmental variance (Vr). The heritability is de-
fined as h 2  = Vg/(Vp – Vr). We accounted for the pedigree struc-
ture by using the kinship matrix as a covariate. The kinship ma-
trix captures the proportion of genes shared in common between 
all pairs of individuals in the family, based on their relationship 
(sibling(s) pairs share 50% of their genes in common, grandpar-
ent-grandchild pairs share 25% of their genes in common, unre-
lated spouses share no gene in common). The likelihood ratio test 
was used to test for significance. Two times the difference be-
tween the log-likelihoods of the two models has a chi-square dis-
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tribution with degree of freedoms equal to the difference in the 
number of covariates in the models that are being compared.
 The association between the traits and HFE polymorphisms 
was tested by including the genotypes as covariates; the genotypes 
were coded as number of ‘Y’ (C282Y) and ‘D’ alleles (H63D). The 
proportion of variance explained by inclusion of the genotypes 
was estimated as (Ve – Ve)/(Vp – Ve), where Ve is variance ex-
plained by sex, age and age 2  and Ve is the variance explained by 
including the above covariates and the genotype. The total sig-
nificance of the inclusion of HFE genotypes was tested using Like-
lihood Ratio Test on 2 degrees of freedom.
 We further investigated whether significant associations be-
tween serum iron parameters could be explained by common ge-
netic influences, shared environmental factors or unmeasured 
non-genetic factors using bivariate analysis. We partitioned the 
phenotypic correlation between a pair of quantitative traits into 
their additive genetic effect and random environmental effect 
taking into account the kinship correlation.
 The significance of the phenotypic, genetic and environmen-
tal correlations were evaluated using the likelihood ratio test by 
comparing the model in which the parameter is set to zero to the 
model in which the parameter is estimated. The inbreeding coef-
ficient was estimated using the PEDIG package  [24] . In all analy-
ses age, age 2 , sex and inbreeding coefficient were included as co-
variates in the model. Serum iron parameters exhibiting a skewed 
distribution were normalized prior to data analysis.
 Results 
 The characteristics of the study population are shown 
in  table 1 . In total of 980 subjects were included in the 
analysis and consisted of a large number of relative pairs, 
including 894 first-degree relative pairs, 652 second-de-
gree relative pairs and 2,360 third degree relative pairs. 
The mean serum iron, ferritin and transferrin saturation 
for men and women are presented in  table 1 . Our refer-
ence range for iron was 10–25 mol/l and 15–50% for 
transferrin saturation. The reference ranges for ferritin 
are not uniform, due to less optimal standardization. 
Therefore reported ferritin values vary greatly between 
laboratories. Our reference values for ferritin were 15–
280   g/l for men, 6–80   g/l for premenopausal women 
and 15–190   g/l for postmenopausal women.
 Figure 1 shows the mean serum iron, ferritin and 
transferrin saturation by HFE C282Y genotype. Serum 
iron, ferritin and transferrin saturation were significant-
ly higher (p  ! 0.001) in women homozygous for the C282Y 
mutation compared to wild type homozygotes. Although 
subjects heterozygous for the C282Y mutation had high-
er serum iron indices compared to wild type homozy-
gotes, this did not reach statistical significance.
 Table 2 shows the heritability estimates (h 2   8 stan-
dard error) for serum iron, serum ferritin and transferrin 
saturation. When HFE C282Y and H63D genotypes were 
considered in the model, the heritability estimates were 
0.20  8 0.07 (p  ! 0.0001) for iron, 0.22  8 0.07 (p  ! 0.0001) 
for ferritin and 0.23  8 0.07 (p  ! 0.0001) for transferrin 
saturation. The effects of HFE C282Y and H63D geno-
types was highly significant (p  ! 0.001 for all three traits). 
The effect of the 282Y allele was 1.49 + 0.54 on serum iron 
level, 80.29 + 11.23 on ferritin and 4.34 + 0.98 on trans-
ferrin saturation. The effect of the 63D allele was some-
what lower: 1.49 + 0.44, 16.22 + 9.11 and 2.81 + 0.77 for 
iron, ferritin and transferrin saturation, respectively. The 
proportion of variance explained by HFE gene mutations 
was 2.1% for serum iron level, 5.6% for ferritin and 3.5% 
for transferrin saturation.
 Table 3 shows the phenotypic (P) and genetic (G) cor-
relations between serum iron, serum ferritin and trans-
ferrin saturation. As expected, there was a high and sig-
nificant phenotypic and genotypic correlation between 
serum iron and serum ferritin.
 The genetic correlation estimates vary little between 
models with and without the HFE genotypes included 
(data not shown). This suggests that HFE mutations 
equally affect serum iron, ferritin and transferrin satura-
tion levels or that there are other, even more important 
pleiotropic genes.
 To test the effect of inbreeding on the results presented 
here, we computed the mean of serum iron parameters by 
level of inbreeding. We categorised subjects into three 
categories; no inbreeding (0) for subjects with no in-
breeding or inbreeding coefficient = 0, low inbreeding (1) 
for subjects with inbreeding coefficient  ^  to the mean 
inbreeding coefficient and high inbreeding coefficient (2) 
for subjects with inbreeding coefficient  1 mean inbreed-
Table 1. Characteristics of the study population
Men, % 40
Age, years 53.5280.47
Serum iron, mol/l
Men 20.9680.33
Women 18.8280.26
Serum ferritin, ng/ml
Men 223.7188.84
Women 99.3484.28
Serum transferrin saturation, %
Men 35.3080.59
Women 30.7880.45
Inbreeding coefficient 0.00680.00004
Figures are mean 8 standard error or percentage.
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ing coefficient.  Figure 2 shows the mean iron indices by 
level of inbreeding. There was a significant difference in 
mean serum ferritin by level of inbreeding, predicting a 
recessive model. We observed no significant difference in 
the mean of serum iron and serum transferrin saturation 
by level of inbreeding.
 Discussion 
 We have studied the contribution of genetic and envi-
ronmental factors on serum iron indices. We found that 
a significant proportion of serum iron (23%), serum fer-
ritin (29%) and transferrin saturation (28%) could be at-
tributed to genetic factors. A large proportion of serum 
iron parameters is determined by environmental factors. 
We also found that serum iron indices are significantly 
 Fig. 1.  Mean (SE) level of serum iron indices by C282Y genotype. 
Serum iron Serum ferritin Serum transferrin
saturation
Covariates
Age + sex + age2 0.2380.07
(p < 0.0001)
0.2980.09
(p < 0.0001)
0.2880.07
(p < 0.0001)
Age + sex + age2 + HFE
genotypes
0.2080.07
(p < 0.0001)
0.2280.07
(p < 0.0001)
0.2380.07
(p < 0.0001)
Figures are proportion of variance 8 standard error.
Table 2. Heritability (h2) estimates
of  serum iron, ferritin and transferrin 
 saturation
Serum iron and serum ferritin P = 0.25, p < 0.001 G = 0.40, p < 0.001
Serum ferritin and serum transferrin saturation P = 0.40, p < 0.001 G = 0.73, p < 0.001
P = Phenotypic correlation; G = genetic correlation.
Table 3. Phenotypic and genetic 
 correlations between serum iron,
ferritin and transferrin saturation
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correlated, indicating that they share common genetic 
and environmental factors.
 Compared to the twin study of Whitfield et al.  [19] , 
our heritability estimates are somewhat lower. This can 
be explained by the differences in study populations. We 
have studied large families from a genetic isolate and we 
have conditioned on the pedigree structure and account-
ed for relationship between individuals in our analysis. 
Heritability estimates from twin studies are based on dif-
ferences in trait correlations between monozygotic and 
dizygotic twin pairs and are based on the assumption that 
environmental influences are the same for both twin 
pairs whereas differences between dizygotic twin pairs 
may be attributable to both genetic and environmental 
factors. Another explanation for the small differences in 
heritability estimates between these two studies can be 
the difference in the population’s genetic make up as they 
studied an Australian population comprising subjects of 
Celtic origin. Celts are known to have a higher frequency 
of the HFE C282Y mutation and therefore increased iron 
stores. It is also possible that different methods of mea-
surements of serum iron indices can lead to subtle differ-
ences in heritability estimates. We have calculated serum 
transferrin saturation using TIBC, whereas Whitfield et 
al.  [19] used transferrin. Although some articles suggest 
that the relation between transferrin and TIBC is not 
fixed, others found that when each test is measured pre-
cisely and without bias, the ratio of TIBC (in   mol/l) to 
transferrin (in g/l) is indeed close to the expected value 
of 25.0  [25, 26] . Also, recent studies found high signifi-
cant correlations between the TIBC and the serum trans-
ferrin values, even without this proposed calibration 
 [27] .
 Our results in this genetic isolate are comparable to 
our previous report in another Dutch population  [22] 
where we found that the HFE genotypes explained less 
than 5% of the variability in serum ferritin and about 6% 
variability in serum transferrin saturation.
 The major strength of our study is its population struc-
ture. We did not only use related individuals but also in-
cluded spouses and relatives not living in the same house-
hold. This has the advantage of reducing confounding by 
shared environment leading to more accurate estimates 
of the genetic effect.
 We found that about 20 to 30% of serum iron indices 
can be attributed to genetic factors. We also observed a 
high genetic correlation between serum iron, ferritin and 
transferrin saturation suggesting that these traits are 
likely regulated by the same genes. It has been reported 
that iron regulates ferritin production  [28] .
 The HFE C282Y and H63D genotypes could explain 2 
to 6% of the sex and age-adjusted variation in iron indi-
ces. This is in agreement with the study of Crawford et al. 
 [14] who found a heritability of 3.5% for serum ferritin in 
sibs with hemochromatosis. The proportions themselves 
(2 to 6 %) may seem small at the first glance. However, for 
the iron levels and transferrin saturation these effects are 
comparable to those exhibited by such important factor 
as sex (2.6% for iron and 3.7% for transferrin saturation). 
Moreover, in the context of genetics of complex traits, an 
effect size in the magnitude of 5% is high. For example, a 
gene that is consistently implicated in human complex 
genetics is the APOE gene. The e2/e3/e4 polymorphism 
of this gene explains about 3 to 5% of the variation of to-
tal cholesterol level  [29] .
 The observation of a 2 to 6% influence of the HFE on 
a complex trait such as iron points to a significant role of 
HFE in the complex iron network. This network accord-
ing to the current knowledge involves numerous other 
proteins connecting several pathways  [30–32] . Also the 
effect estimate for the C282Y and H63D mutations is in 
agreement with the observation that heterozygosity for 
the C282Y mutation in the HFE gene shows increased 
iron parameters compared to wild type and this mutation 
is associated with significantly higher iron loading com-
pared to the H63D  [22] .
 Without being the devil’s advocate, these results bring 
back HFE to the central role it had been given just after 
 Fig. 2.  Mean (SE) iron parameters by degree of inbreeding. 
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its discovery in 1996 but that appears to have faded away 
since (i) the clinical penetrance of homozygosity for the 
C282Y mutation was shown to be low in 2001  [33] , and 
(ii) other proteins of significant importance in iron me-
tabolism were identified the last few years.
 The control of iron homeostasis involves numerous ge-
netic and environmental factors that are part of a wide 
network of metabolic pathways. This regulation appears 
to take place at both the systemic and cellular level with 
the intestine, bone marrow, macrophages and hepatocytes 
as the main regulatory sites and cell types  [31] . In recent 
years, identification and characterization of new trans-
porters, scavengers and regulatory proteins have consider-
ably increased our understanding of iron homeostasis and 
its link with other pathways, such as innate immunity and 
signal transduction that have roles in a myriad of biologi-
cal activities  [31, 32] . The newly identified key players of 
iron metabolism among others include HFE, transferrin 
receptor 2 (TfR2), ferroportin and hemojuvelin, as well as 
the iron regulatory protein hepcidin  [30] . The latter pro-
tein is a small peptide synthesized in the liver in response 
to the total burden of iron, but also to non-iron stimuli 
such as inflammation and oxidative stress.
 Although the exact role of HFE is not known yet, the 
available data do suggest that HFE/TfR1 in parallel to 
TfR2 is implicated in the iron sensing pathway of hepa-
tocytes that controls hepcidin synthesis (reviewed in 
 [34] ). But also HFE in macrophages might influence he-
patic hepcidin expression  [35] .
 Altogether, these proteins, signals and regulatory 
mechanism orchestrate expression of iron genes that in-
volve both genetic and environmental modulation of 
transcription, translation and post-translational modifi-
cations. Thus it is likely that there is a multifactorial in-
fluence on serum iron parameters including a multige-
netic rather than an oligogenetic effect.
 The effect of inbreeding in our study population was 
significant for serum ferritin only, predicting a recessive 
mode of inheritance.
 Future studies aiming at identifying genes influencing 
serum iron and ferritin levels in this population are nec-
essary and can be done using a quantitative trait loci 
(QTL) method.
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